1 of 1
Story summary
- GRAIL, Inc. announced on October 16, 2025 a strategic alliance with Samsung, including a $110 million investment to expand Galleri into South Korea and later Japan and Singapore.
- GRAIL's shares rose about 13–14% to a record high.
- In Q2 2025, Galleri revenue was $35.5 million and the net loss was $114 million.
- Analysts rate the stock as Hold, citing FDA approval and insurer coverage for average-risk patients as key challenges.
